Category Regulatory 491 articles to read

HHSC: Aging Texas Well Advisory Committee

The Aging Texas Well Advisory Committee advises HHSC and makes recommendations to state leadership on implementation of the Aging Texas Well Initiative. Texas Gov. Rick Perry issued an executive order creating the Aging…
Read more

HHSC: Texas HIV Medication Advisory Committee

The Texas HIV Medication Advisory Committee advises in the development of procedures and guidelines for the Texas HIV Medication Program, reviews program's goals and aims, evaluates ongoing efforts, and recommends short-range and long-range goals and objectives. Texas began distributing HIV medications in late 1987 as temporary pilot program; the THMP was officially established in 1989 in Senate Bill 959. The statute that created the HIV Medication Advisory Committee is found in Texas Health & Safety Code, Chapter 85, Sections 85.044 and 85.271-85.282. Rules related to this Committee may be found in Texas Administrative Code, Title 25, Part 1, Chapter 98, Subchapter C, Division 2, Rule 98.121. Committee members are appointed by the Commissioner of the Texas Department of State Health Services.
Read more

HHSC: Joint Committee on Access and Forensic Services

The Joint Committee on Access and Forensic Services develops recommendations for the bed day allocation methodology, the bed day utilization review protocol including a peer review process and advises on a comprehensive…
Read more

HHSC: Palliative Care Interdisciplinary Advisory Council

House Bill (HB) 1874, 84th Legislature, Regular Session, 2015 established the Palliative Care Interdisciplinary Advisory Council to assess the availability of patient-centered and family-focused palliative care in Texas. HB 1874 charges…
Read more

HHSC: Texas Autism Council

The Texas Autism Council advises and makes recommendations to state agencies and the state Legislature to ensure that the needs of persons of all ages with autism and other pervasive developmental…
Read more

HHSC: Drug Utilization Review Board

The Drug Utilization Review Board develops and submits recommendations for the preferred drug list, suggests clinical prior authorizations on outpatient prescription drugs, recommends education interventions for Medicaid providers, and reviews drug usage across Medicaid programs. The DUR board is composed of 20 total members: 18 physicians and pharmacists providing services across the entire population of Medicaid and representing different specialties; two representatives from Medicaid managed care organizations as nonvoting members; and a consumer advocate representing people enrolled in the program.
Read more

HHSC: STAR+PLUS Pilot Program Workgroup

The STAR+PLUS Pilot Program Workgroup advises HHSC on the development, operation and evaluation of a new STAR+PLUS Pilot Program (Pilot) to test the managed care delivery of long-term services and supports…
Read more

HHSC: Supplemental Nutrition Assistance Program (SNAP) Incentive Study Workgroup

The Workgroup gathered to conduct a roundtable discussion on local SNAP Incentive Programs including a presentation on specialty crops, consumer trends, trade, and SNAP; a presentation on the Gus Schumacher Nutrition Incentive Program grant; and strategies members use to encourage the purchase of eligible fruit/vegetables using SNAP.
Read more